ABOUT US
Who We Are
At AgariX Biolab, we are a biotechnology company dedicated to tackling the global crisis of antimicrobial resistance. Our mission is to empower healthcare providers with rapid, reliable, and scalable tools for antibiotic susceptibility testing.
Our Vision
To accelerate time-to-effective therapy and safeguard antibiotics for future generations by redefining how the world diagnoses and combats bacterial infections.
Our Team
We combine expertise in microbiology, bioengineering, AI, and clinical diagnostics to deliver transformative solutions for patients, hospitals, and global health systems.
AgariX: The Future of Rapid AST
3D Microarray Innovation
Miniaturized bacterial cultures in precision-engineered arrays enable rapid, parallel testing of multiple antibiotics simultaneously.
Integrated Sensors
Colorimetric detection with automated imaging provides real-time bacterial growth monitoring and precise susceptibility determination.
AI-Powered Analytics
Advanced algorithms detect early resistance signatures and heteroresistant subpopulations invisible to traditional methods.
Transformative Speed Advantage
24-72 hours for results, forcing empirical broad-spectrum prescribing and delayed targeted therapy.
Limited resistance detection, missing phenotypic variations and novel resistance mechanisms.
3-6 hours for comprehensive, multiparametric results enabling immediate targeted antibiotic therapy.
Clinical Applications Across Healthcare
Healthcare Providers
- Seamless integration into existing clinical workflows for immediate impact on patient care
- Faster targeted therapy decisions
- Reduced hospital stays and costs
- Improved patient outcomes
Hospitals & Reference Labs
- Seamless integration into existing clinical workflows for immediate impact on patient care
- High-throughput, scalable testing
- Integration with existing microbiology workflows
- Lower reliance on empiric prescribing
Global Health Organizations
- Point-of-care testing capabilities for rapid treatment decisions
- Expand access to rapid diagnostics in low-resource regions
- Support antibiotic stewardship programs
- Contribute to global AMR mitigation strategies
TECHNOLOGY PLATFORM OVERVIEW
Sample Processing
Real-Time Detection
Real-Time Detection
Automated bacterial inoculation into precisely calibrated microwell arrays with antibiotic gradients.
Real-Time Detection
Real-Time Detection
Real-Time Detection
AColorimetric sensors monitor bacterial growth patterns with high-resolution automated imaging systems.
AI Analysis
Real-Time Detection
AI Analysis
Machine learning algorithms interpret complex growth patterns to deliver precise susceptibility profiles.
Our Partners
